India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges
On his visit to NIPER Mohali, union health minister vreviews biopharma research initiatives and calls for stronger industry collaboration and commercialization focus
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031
EB-003 is Enveric’s lead neuroplastogen, a 5-HT2A / 5-HT1B dual-acting compound designed to promote neuroplastic changes
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The protections extend through at least 2035, with the potential for further extensions
The Japanese Patent Office has issued a favorable Appeal Decision granting a patent for the use of REQORSA Gene Therapy in combination with PD-L1 antibodies to treat cancer
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
